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Salsolinol, a tetrahydroisoquinoline present in the human and rat brains, is the
condensation product of dopamine and acetaldehyde, the first metabolite of ethanol.
Previous evidence obtained in vivo links salsolinol with the mesolimbic dopaminergic
(DA) system: salsolinol is self-administered into the posterior of the ventral tegmental
area (pVTA) of rats; intra-VTA administration of salsolinol induces a strong conditional
place preference and increases dopamine release in the nucleus accumbens (NAc).
However, the underlying neuronal mechanisms are unclear. Here we present an overview
of some of the recent research on this topic. Electrophysiological studies reveal that DA
neurons in the pVTA are a target of salsolinol. In acute brain slices from rats, salsolinol
increases the excitability and accelerates the ongoing firing of dopamine neurons in
the pVTA. Intriguingly, this action of salsolinol involves multiple pre- and post-synaptic
mechanisms, including: (1) depolarizing dopamine neurons; (2) by activating μ opioid
receptors on the GABAergic inputs to dopamine neurons – which decreases GABAergic
activity – dopamine neurons are disinhibited; and (3) enhancing presynaptic glutamatergic
transmission onto dopamine neurons via activation of dopamine type 1 receptors, probably
situated on the glutamatergic terminals. These novel mechanisms may contribute to the
rewarding/reinforcing properties of salsolinol observed in vivo.
Keywords: reward, addictive property, electrophysiology, brain slices, mu opioid receptors, GABAergic
transmission, glutamatergic transmissions, dopaminergic neurons
INTRODUCTION
Alcohol/Ethanol is one of the most widely used drugs and the
global burden of alcoholism is immense, with an estimated 3.8%
(Rehm et al., 2009) or 3.2% (Spanagel et al., 2010) of world-
wide deaths attributed to alcohol consumption. Accumulating
evidence suggests that some addictive properties of alcohol
are generated by its metabolites, such as acetaldehyde and its
derivatives, notably salsolinol (SAL, 1-methyl-1,2,3,4-tetrahydro-
6,7-dihydroxy-isoquinolines) (Deng and Deitrich, 2008). SAL is
formed from dopamine: either by non-enzymatic Pictet-Spengler
condensation with acetaldehyde, yielding racemic (R/S)-SAL, or
by combination with pyruvic acid, followed by enzymatic decar-
boxylation and reduction, producing (R)-SAL. In the brains of
mammals racemic (R/S)-SAL is formed by the Pictet-Spengler
condensation (Rommelspacher et al., 1995; Haber et al., 1996). In
the human brain, enantio-selective (R)-SAL can be synthesized
from dopamine and acetaldehyde by (R)-SAL synthase (Naoi
et al., 1998). (R/S)-SAL is present in biological fluids such as
urine, plasma, cerebrospinal fluid and postmortem brains of both
alcoholics and non-alcoholics (Sjöquist et al., 1982b; Haber et al.,
1996). The effects of alcohol consumption on SAL concentra-
tions in the biological fluids and the brain have been extensively
reviewed by Hipolito et al. (2012).
Many studies have attempted to establish a correlation between
alcohol ingestion and the increase of SAL levels in brain tissues.
According to the majority, chronic alcohol exposure produces an
increase in SAL levels in several brain regions such as the striatum,
hypothalamus and limbic regions (Sjöquist et al., 1982a,b; Myers
et al., 1985; Matsubara et al., 1987; Rojkovicova et al., 2008).
The increase varied remarkably ranging from 0.08 (Starkey et al.,
2006) to 7.59 pg/mg (Rojkovicova et al., 2008). With one excep-
tion (Haber et al., 1996), previous human studies found that,
after acute (Faraj et al., 1989; Rommelspacher et al., 1995) or
chronic (Faraj et al., 1989) alcohol drinking, SAL levels rise in
plasma (and presumably brain). Recent evidence that SAL in the
brain accounts for some aspects of alcohol’s addictive proper-
ties have been elegantly reviewed (Hipolito et al., 2012; Deehan
et al., 2013a,b); but still little is known about how SAL acts at the
cellular level.
The midbrain ventral tegmental area (VTA) has been exten-
sively studied as a target for the central effects of alcohol
(Morikawa and Morrisett, 2010), its first metabolite acetalde-
hyde (Melis et al., 2009; Karahanian et al., 2011), as well as
its metabolic derivative SAL (Hipolito et al., 2012). The major-
ity of neurons in the VTA are either dopaminergic (DA) or
GABAergic (Lacey et al., 1989; Yung et al., 1991; Johnson and
North, 1992b; Chieng et al., 2011), with only a few gluta-
matergic neurons (Nair-Roberts et al., 2008). The VTA DA
neurons project mainly to the nucleus accumbens (NAc) and
prefrontal cortex (PFC) (Oades and Halliday, 1987). Dopamine
is involved in self-administration of most drugs of abuse, and
drugs abused by humans increase dopamine output in target
regions of the brain (Di Chiara and Imperato, 1988; Volkow
et al., 2007). Addictive substances of different types modulate
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DA neuron activity and dopamine release from the VTA (Lüscher
and Malenka, 2011). Recently, we employed patch clamp in com-
bination with pharmacological techniques to investigate SAL’s
immediate effects on VTA DA neurons in rat brain slices (Xie and
Ye, 2012; Xie et al., 2012). We found that SAL (0.01–1μM) sig-
nificantly stimulates the activity of DA neurons. In this review,
we will focus on the multiple underlying cellular mechanisms,
in order to clarify how SAL modulates neuronal excitability in
the VTA.
SAL’s PSYCHOACTIVE EFFECTS IN THE MESOLIMBIC
DOPAMINE SYSTEM In vivo
Research from several laboratories has led to the idea that SAL
participates in ethanol’s psychoactive effects in rodents through
its own rewarding properties. Early animal studies revealed that
SAL promotes alcohol drinking (Duncan and Deitrich, 1980;
Myers et al., 1982). Recent data from several groups support
the notion that SAL is responsible for some addiction-related
psychoactive behaviors related to the mesolimbic dopamine sys-
tem. Indeed, in Wistar rats, microinjections of SAL (5, 25μM)
into the NAc core increase local dopamine extracellular levels
(measured by HPLC), whereas the same doses of SAL injected
into the NAc shell significantly reduced the dopamine levels
in that subregion (Hipolito et al., 2009). However, microin-
jection of SAL into the posterior VTA increased DA levels in
the ipsilateral accumbens shell by 41% (Hipolito et al., 2009).
Recently, Deehan et al. (2013a,b) also reported that SAL stim-
ulates dopamine release in the posterior ventral tegmental area
(pVTA). In this study, the effects of SAL on dopamine release were
dose-dependent, in an inverted U-shape manner, with 0.3μM
SAL producing a peak dopamine efflux (to 300% of baseline)
and higher concentrations (3μM) a significantly lower response
(Deehan et al., 2013a,b). In parallel with these neurochemical
findings, SAL elicited some behavioral effects. Direct injection of
only 30 pmol SAL into the pVTA resulted in behavioral sensiti-
zation and induced strong motor activity in rats (Hipolito et al.,
2010). Moreover, significant place preference was induced by SAL,
given either intraperitoneally (ip) (Matsuzawa et al., 2000) or by
local microinjection into the pVTA (Hipolito et al., 2011). Rodd
and colleagues found that rats readily self-administered SAL into
the NAc shell (Rodd et al., 2003, 2008) and pVTA (Rodd et al.,
2008). Such reinforcing actions seem to depend on activation of
DA neurons, being reduced by co-infusion of quinpirole [a D
(2, 3) receptor agonist] (Rodd et al., 2008). Below, we will discuss
the possible cellular mechanisms underlying these psychoactive
effects of SAL, in the light of our recent findings in brain slices
in vitro.
SAL DEPOLARIZES pVTA DA NEURONS In vitro AND ACCELERATES
THEIR DISCHARGE
Under current-clamp, SAL was found to depolarize the mem-
brane potential of VTA DA neurons in rats (Xie et al., 2012).
In keeping with this depolarization, SAL increased the firing
rate of DA neurons in a reversible and dose-dependent manner,
with a peak effect at 0.1μM. This dose dependence, however,
was biphasic: at concentrations of 0.01–0.1μM, the firing rate
increased with SAL concentration; but at higher concentrations,
the increase diminished sharply. Such concentrations are within a
pharmacologically relevant range (Matsubara et al., 1987; Haber
et al., 1999). This inverted, U-shaped concentration response
curve seen in vitro is remarkably similar to the concentra-
tion dependence of SAL intra-pVTA microinjections effect on
locomotor activity: this dose-response curve had an inverted
U-shaped profile, with a peak at 30 pmol (Hipolito et al.,
2010). Rodd et al. found that 0.03–0.3μM SAL was readily
self-administered when injected directly into the posterior, not
anterior VTA of Wistar rats (Rodd et al., 2008). Notably, our
in vitro and those in vivo experiments revealed that SAL is far
more potent than ethanol as stimulator of DA neurons in the
pVTA. In contrast to the strong activation induced by 0.1μM
SAL, ethanol had a similar effect only at concentrations of 100–
200mM (Brodie et al., 1990; Xiao et al., 2007). Thus, SAL is 1–2
million times more effective than ethanol as stimulator of DA
neurons in the pVTA.
GABAergic AND GLUTAMATERGIC TRANSMISSIONS IN THE
VTA PLAY A CRITICAL ROLE IN SAL’s EFFECT
DISINHIBITION THROUGH THE ACTIVATION OF µ OPIOID RECEPTORS
(MORs) ON GABAergic AFFERENTS
The projection neurons in the VTA, mostly DA neurons, are
under inhibitory GABAergic control. Several GABAergic inputs
are known, including those from GABA neurons in the rosto-
medial tegmental nucleus (RMTg) (Barrot et al., 2012), local
GABA neurons (i.e., interneurons) (Johnson and North, 1992a;
Lüscher and Malenka, 2011; Omelchenko et al., 2009; Tan et al.,
2012), medium spiny neurons of the NAc and the ventral pal-
lidum (Kalivas, 1993; Kalivas et al., 1993; Hjelmstad et al., 2013).
Both GABAA and GABAB receptors mediate the inhibitory action
of GABA on DA neurons (Johnson and North, 1992a; Brazhnik
et al., 2008; Theile et al., 2011). Both in vivo and in vitro, block-
ade of GABAARs strongly increases DA cell firing (Johnson and
North, 1992a; Xiao et al., 2007; Matsui andWilliams, 2011; Theile
et al., 2011; Guan et al., 2012); GABAergic IPSCs therefore nor-
mally dampen the excitability of DA neurons. GABAAR blockade
in the VTA increases dopamine levels in the NAc (Ikemoto et al.,
1997) and is strongly rewarding (Laviolette and van der Kooy,
2001). Several lines of evidence have linked ethanol-induced
reinforcement to the GABAergic system in the VTA. For exam-
ple, VTA GABA neurons become hyperexcitable during ethanol
withdrawal (Gallegos et al., 1999). Both systemic and intra-VTA
administration of GABAAR agonists facilitate, whereas antago-
nists decrease, voluntary ethanol drinking in rats (Smith et al.,
1992). In line with these in vivo studies, we have recently reported
several relevant findings obtained in vitro, during recordings of
neuronal activity in brain slices from rats (Xiao et al., 2007; Xiao
and Ye, 2008). Thus, ethanol inhibited GABA neurons (through
activation of MORs); it enhanced DA neuron firing. Moreover,
GABAA antagonists such as bicuculline and gabazine, attenu-
ate the ethanol-induced increase in firing of VTA-DA neurons.
Further tests revealed an involvement of μ opioid receptors
(MORs) as the MOR agonist DAMGO and MOR antagonist nal-
trexone significantly attenuated the increase in firing induced by
ethanol and even altered the basal firing rate of the DA neu-
rons, indicating ongoing opioid modulation (Xiao et al., 2007;
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Xiao and Ye, 2008). By contrast, Theile (Theile et al., 2011)
reported that while ethanol-acceleration of the firing rate of
VTA DA neurons was increased by picrotoxin, an antagonist of
GABAA and glycine receptors, it was unaffected by naltrexone,
and DAMGO did not change the ongoing firing. This apparent
difference suggests some links between MORs, GABAARs and the
effect of ethanol on DA neurons.
Compared to the role of GABA in ethanol abuse, we know
much less about how SAL affects GABAergic transmission.
Previous studies have found that SAL is a morphine-like alka-
loid. It binds to opioid receptors and has opioid-like effects (Fertel
et al., 1980; Lucchi et al., 1982). We found (Xie et al., 2012) that
both gabazine and naltrexone reduce the acceleration of DA neu-
ronal firing produced by SAL, suggesting that SAL’s action may
be mediated via MOR on GABAergic neurons. In support of this
idea, SAL reduced the frequency of spontaneous IPSCs recorded
in DA neurons, without changing their amplitude; but SAL
decreased the size of evoked IPSCs and increased the paired-pulse
ratio. These observations indicate that SAL depresses GABAergic
transmission to DA neurons by an opioid sensitive presynaptic
mechanism. Indeed, SAL’s effect on sIPSCs was suppressed by
naltrexone or DAMGO. MORs are enriched in the VTA and are
primarily located on non-DA neurons (Mansour et al., 1995),
the RMTg and its efferents to the DA neurons (Jhou et al., 2009;
Jalabert et al., 2011; Matsui and Williams, 2011; Hjelmstad et al.,
2013). It is generally believed that MORs–mediated inhibition
of GABAergic neurons leads to excitation of DA neurons by a
disinhibitory mechanism (Johnson and North, 1992a; Jalabert
et al., 2011; Matsui and Williams, 2011). In keeping with this
idea, both systemic and intra-VTA administrations of MOR ago-
nists increase VTA DA neuron firing and NAc dopamine release
(Matthews and German, 1984; Latimer et al., 1987; Di Chiara and
Imperato, 1988; Leone et al., 1991; Spanagel et al., 1992). Previous
experiments in vivo have shown that SAL-associated place pref-
erence was blocked by intraperitoneal or local administration
of β-Funaltrexamine, an antagonist of MORs (Matsuzawa et al.,
2000). Local pretreatment with β-Funaltrexamine hydrochloride
also prevented the SAL-evoked increase in NAc dopamine lev-
els (Hipolito et al., 2011). Our observation of pronounced effects
of naltrexone on GABAergic IPSCs is strong evidence of ongo-
ing opioid release in the VTA (Xiao et al., 2007; Xiao and Ye,
2008; Xie et al., 2012). Moreover, naltrexone largely eliminated
the effects of SAL on DA neurons. The simplest explanation of
our results is that SAL activates MORs on GABAergic neurons
or their efferents, thus exciting VTA DA neurons by disinhibi-
tion. Overall, our in vitro findings are consistent with the notion
that SAL’s excitatory effects in rat pVTA are mediated, at least
partly, by activation of MORs (Hipolito et al., 2011) and the
resulting suppression of GABAergic inhibition. How SAL acti-
vates MORs remains to be clarified. Though known to bind
to opioid receptors, it has only a low affinity, significant bind-
ing requiring relatively high micromolar concentrations of SAL
(Fertel et al., 1980; Lucchi et al., 1982). The binding of SAL lowers
the binding of endogenous opioids. Therefore, other mecha-
nisms of SAL action at very low concentrations, such as enhanced
release or slower removal of endogenous opioid, should also be
considered.
GLUTAMATERGIC TRANSMISSION TO VTA IS ENHANCED BY
SAL-INDUCED ACTIVATION OF D1Rs
VTA DA neurons receive numerous glutamatergic afferents from
many parts of the brain, including the PFC (Sesack et al., 2003;
Geisler et al., 2007) and subcortical structures, such as the pedun-
culopontine (PPTg) and laterodorsal tegmental (LDTg) nuclei
(Charara et al., 1996; Clements et al., 1991; Lavoie and Parent,
1994), the bed nucleus of the stria terminals (BNST) (Georges and
Aston-Jones, 2002), the superior colliculus (SC) (Comoli et al.,
2003; Dommett et al., 2005), the lateral hypothalamic and pre-
optic areas, periaqueductal gray, the dorsal and median raphe
(Geisler et al., 2007), as well as the lateral habenula (Gonçalves
et al., 2012). Some glutamatergic neurons are also present within
the VTA (Dobi et al., 2010). Excitatory synaptic inputs which
activate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA), and NMDA-type ionotropic glutamate receptors in
DA neurons are a key component in the regulation of DA
cell excitability (Overton and Clark, 1997). Accordingly, ion-
tophoretic applications of both AMPA and NMDA receptor ago-
nists can stimulate DA neuron firing (Christoffersen and Meltzer,
1995; Zhang et al., 1997). Consistently, applications of APV +
DNQX (AMPA and NMDA receptor antagonists, respectively)
slightly but significantly lower the firing rate of DA neurons (Xie
and Ye, 2012).
Glutamatergic transmission plays an important role in the
effects of ethanol (Eckardt et al., 1998; Krystal et al., 2003).
In several brain regions, ethanol inhibits NMDA and non-
NMDA glutamate receptors, as well as glutamate release (Siggins
et al., 2005). However, ethanol can increase glutamate release
under some circumstances. Systemic administration of ethanol
increases glutamate release in the NAc of low-alcohol sensi-
tive rats (Dahchour et al., 2000) and addiction-prone Lewis
rats (Selim and Bradberry, 1996). Acute ethanol administra-
tion increases glutamate release in the central nucleus of the
amygdala from rats receiving chronic ethanol treatment (Roberto
et al., 2004; Zhu et al., 2007). Both acute and repeated expo-
sure to low doses of ethanol raised glutamate levels in the
pVTA (Ding et al., 2012). We have previously reported that
ethanol enhances glutamatergic transmission to VTA DA neu-
rons (Deng et al., 2009; Xiao et al., 2009). Most recently, we
found that SAL also enhances glutamatergic transmission to DA
neurons in the VTA, increasing the frequency of both firing
and spontaneous EPSCs (Xie and Ye, 2012). The application of
APV + DNQX substantially attenuated SAL’s action on firing,
indicating a very substantial glutamatergic component in SAL-
induced excitation of DA neurons. The increase in frequency
of spontaneous EPSCs was abolished by the sodium channel
blocker tetrodotoxin, indicating that SAL’s effect involved voltage-
dependent Na+ channels. Since SAL did not alter the amplitude of
either sEPSCs or mEPSCs, but increased the EPSC2/EPSC1 ratio
during paired-pulse stimulation, its site of action was probably
presynaptic. These findings clearly point to the involvement of
glutamatergic transmission in SAL’s effects in VTA. Dopamine
receptors consist of D1-like (D1 and D5 receptors) and D2-
like (D2, D3, and D4 receptors) families. Both D1R and the
D2R family (D2R in particular) have been implicated in the
mechanisms of drug dependence and abuse (Blum et al., 1990).
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Disruption of D1R gene expression (El-Ghundi et al., 1998)
or administration of a D1R antagonist (Liu and Weiss, 2002)
attenuates or prevents alcohol-seeking behavior. In the VTA,
D1Rs are expressed on glutamatergic axons (Lu et al., 1997) but
not on the soma of VTA DA neurons (Mansour et al., 1992; Lu
et al., 1997). The activation of D1Rs increases glutamate lev-
els in the VTA (Kalivas and Duffy, 1995). In our experiments,
SKF83566 (a selective D1R antagonist), suppressed SAL’s action
on evoked EPSCs in VTA, confirming that the enhancement of
glutamatergic transmission wasmediated by D1Rs.We also found
that SKF83566 attenuated the SAL-induced acceleration of DA
neuron firing. SAL may thus increase the somatodendritic release
of dopamine; and by raising the extracellular level of dopamine
may retrogradely activate the D1Rs on the glutamate-releasing
terminals, which in turn increases glutamate release and the
excitability of DA neurons. Somatodendritic release of dopamine
in the midbrain DA neurons is Na+ channel-dependent (Threlfell
and Cragg, 2007). In keeping with this, we found that the increase
in the frequency of spontaneous EPSCs by SAL was abolished by
tetrodotoxin. SAL’s D1R-dependent effect on glutamatergic trans-
mission is similar to that we observed previously with ethanol
(Deng et al., 2009; Xiao et al., 2009); but SAL is much more
potent than ethanol (the effective concentrations being 0.1μM
for SAL vs. 40mM for ethanol). This is consistent with both
in vivo and in vitro findings that the DA system is particularly
sensitive to SAL (Hipolito et al., 2011; Rodd et al., 2008; Xie and
Ye, 2012).
We showed that the ethanol-induced increase in the release of
glutamate (EPSCs) in the VTA was eliminated when dopamine
was depleted by pretreatment with reserpine (Deng et al., 2009;
Xiao et al., 2009). Since SAL is the condensation product of
dopamine and acetaldehyde, depletion of dopamine could pre-
vent the formation of SAL. This could explain why ethanol
failed to increase glutamatergic transmission when dopamine was
depleted.
SUMMARY
Our in vitro findings in combination with in vivo experi-
ments by other groups—reviewed here—identify cellular mech-
anisms underlying SAL’s psychoactive effects on the mesolimbic
dopamine system. SAL’s stimulating action in the pVTA involves
modulation of synaptic inputs and intrinsic properties of DA neu-
rons (schematically depicted in Figure 1): (1) depolarizing DA
neurons and increasing their firing rate; (2) activating MORs
FIGURE 1 | Schematic representation of the mechanisms underlying
SAL’s excitation of putative DA neurons in rat Pvta. (1) Depolarizing the
membrane and increasing the firing rate. (2) Activation of MORs on the
GABAergic neurons and/or their afferents reduces GABA release onto DA
neurons. (3) Activation of D1Rs at the glutamatergic afferents increases
glutamate release onto DA neurons. VTA, ventral tegmental area.
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on the GABAergic neurons, which inhibit GABAergic trans-
mission to VTA DA neurons (resulting in disinhibition); (3)
enhancing glutamatergic transmission to DA neurons by acti-
vating D1Rs situated on glutamatergic afferents. Thus, by acting
on both presynaptic and postsynaptic targets on the DA neu-
rons, SAL enhances the discharge of VTA DA neurons and so
increases dopamine release in the downstream brain regions.
Whatever its precise role—whether as detector of rewarding
stimuli (Mirenowicz and Schultz, 1996) or modulating network
activity in PFC (Durstewitz et al., 2000; González-Burgos et al.,
2002; Lapish et al., 2007)—it is clear that the mesocortical DA
system is important in processes leading to addiction. Hence,
the novel mechanisms proposed here may contribute to the
rewarding properties of SAL observed in vivo. Understanding
how SAL affects the activity of VTA dopamine neurons could
have profound implications for the prevention and treatment of
alcoholism.
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